ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,529, issued on Feb. 24, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).
"NPY2 receptor agonists" was invented by Peter Wilhelm Haebel (Mittelbiberach, Germany), Albert Brennauer (Riedlingen, Germany), Charlotte Stahl Madsen (Malov, Denmark), Soren Ljungberg Pedersen (Borup, Denmark) and Stefan Peters (Biberach an der Riss, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to PYY analogues having alanine at position 4, lysine at position 7, QRY as the C-terminal end and a half-life extending group. The analogues of the invention are soluble around pH 6 and 7. The invention also relates...